Non-bacterial infections in allogeneic non-myeloablative stem cell transplant recipients
- PMID: 17313464
- DOI: 10.1111/j.1399-3062.2006.00172.x
Non-bacterial infections in allogeneic non-myeloablative stem cell transplant recipients
Abstract
Data on non-bacterial infections during allogeneic non-myeloablative hematopoietic stem cell transplantation (HSCT) are widely different. We evaluated data on 48 consecutive patients who received a conditioning regimen with fludarabine and cyclophosphamide (73%) or fludarabine and total body irradiation (27%) and then underwent allogeneic non-myeloablative HSCT. Cytomegalovirus (CMV) infection was common and occurred in 48% of patients; 3 patients developed CMV disease, and all survived. CMV reactivation was found to be common with both conditioning regimens in our patient population. Invasive aspergillosis occurred in 4 patients (8%) and 3 died. Other serious non-bacterial infections were uncommon. Review of the available literature on non-myeloablative HSCT suggests that the frequency and type of opportunistic infections vary considerably.
Similar articles
-
New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2.Bone Marrow Transplant. 2007 Sep;40(6):541-7. doi: 10.1038/sj.bmt.1705770. Epub 2007 Jul 16. Bone Marrow Transplant. 2007. PMID: 17637692
-
Regimen-related mucosal injury of the gut increased the incidence of CMV disease after allogeneic bone marrow transplantation.Biol Blood Marrow Transplant. 2009 Jun;15(6):679-85. doi: 10.1016/j.bbmt.2009.02.006. Epub 2009 Apr 11. Biol Blood Marrow Transplant. 2009. PMID: 19450752
-
Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.Biol Blood Marrow Transplant. 2009 Nov;15(11):1376-85. doi: 10.1016/j.bbmt.2009.06.017. Epub 2009 Aug 19. Biol Blood Marrow Transplant. 2009. PMID: 19822296 Clinical Trial.
-
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.Dan Med Bull. 2007 May;54(2):112-39. Dan Med Bull. 2007. PMID: 17521527 Review.
-
Major complications following hematopoietic stem cell transplantation.Semin Respir Crit Care Med. 2006 Jun;27(3):297-309. doi: 10.1055/s-2006-945530. Semin Respir Crit Care Med. 2006. PMID: 16791762 Review.
Cited by
-
Patients at high risk of invasive fungal infections: when and how to treat.Drugs. 2008;68(14):1941-62. doi: 10.2165/00003495-200868140-00002. Drugs. 2008. PMID: 18778118 Review.
-
Neurological complications of transplantation: part I: hematopoietic cell transplantation.Neurohospitalist. 2013 Jan;3(1):24-38. doi: 10.1177/1941874412455338. Neurohospitalist. 2013. PMID: 23983885 Free PMC article.
-
Overview of Infections in the Immunocompromised Host.Microbiol Spectr. 2016 Aug;4(4):10.1128/microbiolspec.DMIH2-0026-2016. doi: 10.1128/microbiolspec.DMIH2-0026-2016. Microbiol Spectr. 2016. PMID: 27726779 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical